50th ASH Annual Meeting.
Fricker
Janet
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D017762:Nadroparin / Q000627:therapeutic use*; D000069283:Rituximab; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*; D014527:Uric Acid / Q000097:blood*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017762:Nadroparin; D014527:Uric Acid; D000069283:Rituximab; D013792:Thalidomide; D000077269:Lenalidomide